Thomas Jefferson University

Susan Lanza-Jacoby

TitleAssoc Prof CHP
InstitutionThomas Jefferson University
DepartmentNursing - Undergraduate
Address1025 Walnut St.
Philadelphia PA 19107
Phone215-955-7903
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lanza-Jacoby S, Cheng G. 3,3'-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen species. Pharm Biol. 2018 Dec; 56(1):407-414. PMID: 30301388.
      Citations:    
    2. Cheng G, Lanza-Jacoby S. Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: Role of NOX4. Biochem Biophys Res Commun. 2015 Sep 11; 465(1):41-6. PMID: 26225747.
      Citations:    
    3. Yan G, Lanza-Jacoby S, Wang C. Nexrutine inhibits survival and induces g1 cell cycle arrest, which is associated with apoptosis or autophagy depending on the breast cancer cell line. Nutr Cancer. 2014 Apr; 66(3):506-16. PMID: 24206214.
      Citations:    
    4. Lanza-Jacoby S, Yan G, Radice G, Lephong C, Baliff J, Hess R. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer. Exp Biol Med (Maywood). 2013 Jul 1; 238(7):787-97. PMID: 23828595.
      Citations:    
    5. Yan G, Graham K, Lanza-Jacoby S. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol Carcinog. 2013 May; 52(5):404-11. PMID: 22290509.
      Citations:    
    6. Raval M, Frank PG, Laury-Kleintop L, Yan G, Lanza-Jacoby S. Celecoxib combined with atorvastatin prevents progression of atherosclerosis. J Surg Res. 2010 Oct; 163(2):e113-22. PMID: 20538289.
      Citations:    
    7. Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker-Menezes D, Wang M, Lisanti MP, Lanza-Jacoby S, Pestell RG, Wang C. PPARgamma activation induces autophagy in breast cancer cells. Int J Biochem Cell Biol. 2009 Nov; 41(11):2334-42. PMID: 19563910.
      Citations:    
    8. Jacob S, Laury-Kleintop L, Lanza-Jacoby S. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. J Surg Res. 2008 May 1; 146(1):135-42. PMID: 17950326.
      Citations:    
    9. Thangasamy T, Sittadjody S, Lanza-Jacoby S, Wachsberger PR, Limesand KH, Burd R. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer. 2007; 59(2):258-68. PMID: 18001220.
      Citations:    
    10. Lanza-Jacoby S, Burd R, Rosato FE, McGuire K, Little J, Nougbilly N, Miller S. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6161-9. PMID: 17062693.
      Citations:    
    11. Lanza-Jacoby S, Dicker AP, Miller S, Rosato FE, Flynn JT, Lavorgna SN, Burd R. Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice. Mol Cancer Ther. 2004 Apr; 3(4):417-24. PMID: 15078985.
      Citations:    
    12. Lanza-Jacoby S, Miller S, Flynn J, Gallatig K, Daskalakis C, Masferrer JL, Zweifel BS, Sembhi H, Russo IH. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice. Cancer Epidemiol Biomarkers Prev. 2003 Dec; 12(12):1486-91. PMID: 14693742.
      Citations:    
    13. Lanza-Jacoby S, Miller S, Jacob S, Heumann D, Minchenko AG, Flynn JT. Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice. J Endotoxin Res. 2003; 9(6):341-7. PMID: 14733720.
      Citations:    
    14. Phetteplace HW, Sedkova N, Hirano KI, Davidson NO, Lanza-Jacoby SP. Escherichia coli sepsis increases hepatic apolipoprotein B secretion by inhibiting degradation. Lipids. 2000 Oct; 35(10):1079-85. PMID: 11104013.
      Citations:    
    Lanza-Jacoby's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (93)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _